T. Bombeli et al., CYCLOSPORINE-INDUCED DETACHMENT OF VASCULAR ENDOTHELIAL-CELLS INITIATES THE INTRINSIC COAGULATION SYSTEM IN PLASMA AND WHOLE-BLOOD, The Journal of laboratory and clinical medicine, 127(6), 1996, pp. 621-634
Citations number
52
Categorie Soggetti
Medical Laboratory Technology","Medicine, General & Internal
Cyclosporine A (CsA) is supposed to alter the metabolism of vascular e
ndothelial cells, leading to a prothrombotic state. We examined by whi
ch mechanism human umbilical vein endothelial cells (HUVECs) treated w
ith CsA would promote coagulation in human plasma and in whole blood.
Treatment of HUVECs with CsA at concentrations clinically used led to
dose-dependent cell detachment, with the subsequent exposure of the hi
ghly procoagulant connective tissue. As determined by scanning electro
n microscopy, cell counting of detached and adherent cells, and antige
nic measurement of collagen exposure, HUVECs treated with 0.4 mu g/ml
CsA (or more) for 4 days exhibited significant amounts of subendotheli
al areas. On CsA-treated HUVEC monolayers, the clotting time of recalc
ified citrated platelet-rich plasma (PRP), but not platelet-poor plasm
a (PPP), was dose-dependently shortened. Likewise, the onset of thromb
in generation was significantly earlier. Except at a high concentratio
n of 8.0 mu g/ml CsA, there was no procoagulant effect when PPP was us
ed. To investigate CsA-treated HUVECs in whole blood, cells were culti
vated on globular microcarriers and were incubated with nonanticoagula
ted whole blood. When untreated cells were used, generation of factor
Xa, thrombin, and kallikrein was completely suppressed for 30 minutes.
HUVEC beads treated with 0.4 and 0.8 mu g/ml CsA, however, led to a d
ose-dependent generation of all three coagulation factors, with peak v
alues at 2.5 to 5 minutes. Extrinsic activation was excluded, since Cs
A treatment did not induce tissue factor activity in HUVECs. Furthermo
re, the thrombomodulin activity of HUVECs was not altered by CsA. In c
onclusion, treatment of HUVECs with CsA for 4 days at concentrations c
linically used leads to the exposure of subendothelial areas that indu
ce activation of the intrinsic coagulation in recalcified PRP and nona
nticoagulated whole blood.